Related by context. Frequent words. (Click for all words.) 70 Amrubicin 69 indolent NHL 69 relapsed multiple myeloma 69 metastatic renal cell carcinoma 68 lymphoma CTCL 67 Torisel 67 HER2 positive metastatic breast 67 HRPC 66 mTOR inhibitor 66 relapsed refractory 66 glioblastoma multiforme GBM 66 cutaneous T cell 66 Fludara 66 luteinizing hormone releasing 66 gastrointestinal stromal tumors 65 Acute Myeloid Leukemia AML 65 pertuzumab 65 plus prednisone 65 chronic lymphocytic leukemia CLL 65 decitabine 65 hepatocellular carcinoma HCC 65 Irinotecan 65 relapsed refractory multiple myeloma 65 elotuzumab 65 B CLL 65 Chronic Lymphocytic Leukemia 65 malignant pleural mesothelioma 65 TREANDA 65 deforolimus 65 humanized anti 65 GvHD 65 ATL# [001] 65 tyrosine kinase inhibitor 65 TORISEL 64 biologic therapy 64 Pirfenidone 64 metastatic hormone refractory 64 refractory multiple myeloma 64 pulmonary arterial hypertension PAH 64 imatinib mesylate 64 methylnaltrexone 64 superficial bladder cancer 64 androgen independent 64 ofatumumab 64 romidepsin 64 NSCLC 64 adecatumumab 64 chronic myeloid leukemia CML 64 Taxotere ® 63 tumor lysis syndrome 63 hepatitis C HCV 63 Alemtuzumab 63 secondary hyperparathyroidism 63 registrational trial 63 chlorambucil 63 angiogenesis inhibitor 63 axitinib 63 advanced carcinoid 63 Lenalidomide 63 heavily pretreated 63 Everolimus 63 nilotinib 63 EGFR inhibitors 63 EGFr 63 MEK inhibitor 63 Pivotal Phase III 63 follicular non 63 FLT3 63 APOPTONE 63 ocrelizumab 63 orally bioavailable 63 glufosfamide 63 AA amyloidosis 63 orphan medicinal product 63 idiopathic pulmonary fibrosis IPF 63 plus gemcitabine 63 OncoVEX GM CSF 63 goserelin 63 temsirolimus 63 renal cell carcinoma 63 vinorelbine 62 thymalfasin 62 castration resistant prostate cancer 62 azacitidine 62 Rituximab 62 Ofatumumab 62 hormone refractory prostate cancer 62 induces apoptosis 62 BRAF mutation 62 cholangiocarcinoma 62 Diamyd ® 62 Onalta 62 hepatocellular carcinoma 62 anticancer compound 62 MORAb 62 hematological cancers 62 breast carcinoma 62 hematologic malignancies 62 non Hodgkin lymphomas 62 Natalizumab 62 unresectable